Research Makes Case for Expanding apoB Cholesterol Testing
The Limitations of Standard Cholesterol Testing
Standard cholesterol panels typically focus on LDL (low-density lipoprotein) cholesterol levels, often referred to as "bad" cholesterol. However, a growing body of research suggests this approach may not always identify patients at highest risk of cardiovascular events.
What apoB Testing Reveals
Apolipoprotein B (apoB) is a protein found on the surface of harmful cholesterol particles, including LDL. Unlike traditional LDL tests that estimate cholesterol content, apoB testing directly counts the number of atherogenic particles circulating in the blood. This measurement may provide a more accurate picture of cardiovascular risk.
Study Findings
Researchers found that using apoB testing to guide treatment decisions could help prevent more heart attacks and strokes compared to relying solely on LDL cholesterol measurements. The analysis also determined that wider adoption of apoB testing would remain cost-effective for the U.S. healthcare system.
Implications for Clinical Practice
The findings suggest that apoB testing could become an important tool for more precisely targeting cholesterol-lowering therapies to patients who would benefit most from intensive treatment. However, further discussion among medical professionals and guideline committees would be needed before any widespread change in testing practices.